Premium
Alseres Pharmaceuticals Inc (CE) (ALSE)
USOTC
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Alseres Pharmaceuticals, Inc. Reports License of Altropane® Worldwide Rights to Navidea Biopharmaceuticals, Inc. Conference Call to be Held Wednesday, August 1, 2012 at 11:00 a.m. Eastern...
HOPKINTON, Mass., May 7 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE; Alseres) announced today that effective on Friday, May 8, 2009 trading in its shares on the NASDAQ...
HOPKINTON, Mass., April 30 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE; the Company) announced today that on April 24, 2009 it entered into an Amendment to License...
HOPKINTON, Mass., Jan. 12 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. today announced that on January 8, 2009, it received notice from the NASDAQ Stock Market ("NASDAQ") that for the...
HOPKINTON, Mass., June 8 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NASDAQ:BLSINASDAQ:andNASDAQ:ALSE) today announced that its proposed name change to Alseres Pharmaceuticals, Inc...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.005 | 0.005 | 0.005 | 0 | 0 | CS |
| 156 | -0.005 | -50 | 0.01 | 0.01 | 0.005 | 10 | 0.00797546 | CS |
| 260 | -9.9951 | -99.9500005 | 10.0001 | 10.0001 | 0.005 | 13 | 4.64149236 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
